Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • BGMI Continues Its Reward Streak With Redeem Codes on 16th January Lifestyle
  • From Chicago to Monkhood: The Extraordinary Journey of Akhand Swami Ji Lifestyle
  • Greenman Viral Desai organises bike rally to support Save Soil movement Press Release
  • New Book ‘D2C Growth Blueprint’ Unveils Actionable Roadmap to Scale Direct-to-Consumer (D2C) Brands Efficiently Business
  • RE Sector Experts confident in further growth in demand for Western Suburbs in the coming years, Capturing Over 50% Market Share in MMR’s Sales for 2023 Business
  • IGP Launches ‘Find My Santa’ to Transform How India Plays Secret Santa This Christmas Technology
  • SEIL Accelerates Its Debt Free Journey, Repays Total ₹102 Cr (30% of Total Debt) Since December 2025 Business
  • OPPO India launches F31 5G Series: The Best Smartphone for Durability with Smooth and powerful performance Business

Akums Drugs receives EU GMP approval for two Haridwar-based manufacturing plants

Posted on July 11, 2022 By

Akums Drugs & Pharmaceuticals Ltd. has recently received European Union GMP approval for two of their manufacturing units in Haridwar.

New Delhi (India), July 11: Akums Drugs & Pharmaceuticals Ltd., the leading contract manufacturing pharmaceutical company in India, has recently acquired the stringent European Union (EU) GMP  approval for two of their manufacturing units in Haridwar. Following this prestigious nod, the gateway for several new opportunities in the European and other stringent regulatory markets is open to Akums Drugs. This move is another assent to Akums’ “Quality First” approach to work, which has now been endorsed by the EU -GMP beside all top-notch Indian and multinational pharmaceutical companies, who are already Akums’ long-standing partners.

Akums has received EU GMP approval for its two manufacturing plants. One plant manufactures solid oral dosage forms such as tablets, hard gelatin capsules, powders in sachets, etc. belonging to the general category, and Another plant manufactures large volume parenteral and small volume parenterals lines, including vials, ampoules, eyedrops, FFS  as well as for dry powder injections in the penicillin line.

Founder, Promoter and Director, Akums Drugs & Pharmaceuticals, Shri Sandeep Jain, says, “We are happy to announce that Akums Drugs has received EU GMP approval for two of our Haridwar-based manufacturing facilities, thus paving the path for new opportunities from the entire European Union as well as many other regulatory markets. We are already the largest Indian contract manufacturing company, manufacturing > 12% of country’s domestic supply, but what makes us happiest is being recognised for our “Quality First” approach. While we have been endorsed for this quality by our partners, who are also leading Indian and multinational pharmaceutical companies, the latest one from the EU GMP is very widely recognised & accepted. Congratulations to the entire team, and I hope this is the beginning of numerous possibilities for us.”

Founder, Promoter and Director Akums Drugs & Pharmaceuticals, Shri Sanjeev Jain, says, “Akums is already exporting to over 50 countries worldwide. With the esteemed EU GMP nod, we have now gained access to the most stringent global pharmaceutical markets besides the USA. These include the entire European Union, other markets like South Africa, Canada, Malaysia, Indonesia, Thailand, Australia/New Zealand and most middle-eastern countries. Since the EU GMP is their gold standard, we are welcome to cater to the pharmaceutical demands of all these geographies. With a large R&D infrastructure already in place, we are well equipped with a good basket of Products in our pipeline to expand our presence in these regulated markets. While we are extremely proud and excited to expand our presence in these markets, the Indian domestic market has always been our pride & passion and will continue to be so. The trust our partners have in us, and our Quality is paramount for us. ”

Akums Drugs & Pharmaceuticals Ltd. is India’s largest contract manufacturing pharmaceutical company, manufacturing more than 12% of India’s consumption. The organisation deals in manufacturing and exporting formulations in a broad spectrum of dosage forms & therapeutic segments. The company currently supplies to almost all Indian and multinational pharmaceutical companies across the globe and is the 67th largest employer in the country. The ten state-of-the-art facilities are dedicated to oral solid dosage forms (with separate units for beta lactum and non-beta lactum formulations), Oral liquid dosage forms, Sterile dosage forms (injectable, eye, ear & nasal), hormonal (oral and injectable), ointments & cosmetics, personal care,  Ayurvedic, food supplements & nutraceuticals and animal health care.

In a few years, the organisation has become the icon of the Indian pharmaceutical manufacturing industry and currently manufactures more than 12% of the country’s total medicinal requirements. With creme-de-la-creme of dedicated pharmaceutical personnel and standardised practices, Akums has been successful in attaining national and international accreditations and building trust-based on efficacy, safety & quality. The organisation is certified with WHO-GMP, ISO 9001:2015, ISO 14001:2015 certificates and various international accreditations, like; ANVISA, Brazil, NAFDAC, Nigeria, FDB, Ghana, PMPB, Malawi, amongst others and exports to 53 countries across the world.

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Business Tags:Business

Post navigation

Previous Post: KPar Smart Products Announces 1 year report on Smart Cities
Next Post: La Excellence announced the launch of its Batch-2 for students aspiring to enter into the Civil Services in Telangana on July 11

Related Posts

  • India Fashion Awards Season Two A Fashionable Soiree Business
  • Revolutionizing the World: “Sanatani” – Unveiling the True Power of Vedic Rituals Business
  • An NFT entrepreneur says, “NFT Staking can be the next big moneymaker.” Business
  • Yash Sharma – From Engineer to Exporter Business
  • Ashton Gray Investments Stages Prominent ‘Grayvolve’ Event, Unveils New Georgetown Investment Venture Business
  • Find Your Mojo: Transformative Residency Retreats by The Bonding Boulevard Business

Recent Posts

  • Würfel Unveils The Mansion: A New Destination for Luxury, Design & Architectural Dialogue
  • IEM, UEM bring Global Research Exposure to Indian Students, Faculty at IEEE UEMCON 2026 in New York
  • Kisan Cricket League Launches One of India’s Largest Nationwide Talent-Hunt Platforms, Taking Rural Cricketers and Music Performers to The National Stage
  • Kolkata culturist Sundeep Bhutoria inaugurates India National Stand at Frankfurt Book Fair 2026
  • Suvidh Diamond: Why This Navratri, Jewellery Is Becoming More About Personal Style Than Tradition

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • WILDFIT launches its new branch in Kalyani Nagar; Eyes further expansion in Baner Lifestyle
  • Dharmaj Crop Guard’s IPO is coming soon into market   Business
  • LANXESS India wins the FICCI Chemicals & Petrochemicals Award 2023 for Sustainability- Excellence in Safety Lifestyle
  • Kellton Tech Solutions Approves Rights Issue to Raise Funds Business
  • “The Last White Man in India” Becomes a Surprise Hit Press Release
  • MP CR Patil launches Brand Surat logo Business
  • Cooling the Nation: Hamster AC’s 10-Year Journey Business
  • Tirupati Packers and Movers Expands Nationwide Relocation Services Across India Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme